Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Greenway Medical Merger Agreement & One Hedge Fund’s Massive Stake

Greenway Medical merger: Greenway Medical Technologies, Inc. (NYSE:GWAY) recently entered into a merger agreement, according to a filing from one of its shareholders, Pamlico Capital, which holds 17.8% of its shares. Under the terms of the agreement VCG Holdings and Crestview Acquisition Corp will purchase all of the outstanding shares of Greenway Medical Technologies for a price of $20.35 per share.

Greenway Medical Technologies, Inc.

Pamlico Capital owns 5.3 million shares of Greenway Medical Technologies, with the value of the stake amounting to $107.8 million. For its fiscal year ended June 30, Greenway Medical reported a net loss of $5.1 million, versus an income of $2.9 million in the previous fiscal year. For FY2014, the company forecasted a net loss between $6.3 million and $5 million, Greenway said in a statement.

In addition to Pamlico, some hedge funds also disclosed ownership of Greenway Medical Technologies in the latest round of 13F filings. As follows, CR Intrinsic Investors, an SAC Capital Subsidiary, owned 307,300 shares, followed by Chuck Royce’s Royce & Associates with 150,000 shares, and D. E. Shaw’s D. E .Shaw & Co. Check back here for more updates on the Greenway Medical merger.

Recommended Reading:

Hedge Fund News: Carl Icahn, Bill Ackman & Man Group’s Sell Ratings

The Scoop on Bill Ackman’s Air Products & Chemicals Bombshell

Is RTI Surgical a Good Buy? The Newly-Formed Hedge Fund Thinks So

Disclosure: none

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!